<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2017-05-10" version="202">
<accession>P43403</accession>
<accession>A6NFP4</accession>
<accession>Q6PIA4</accession>
<accession>Q8IXD6</accession>
<accession>Q9UBS6</accession>
<name>ZAP70_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase ZAP-70</fullName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>70 kDa zeta-chain associated protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Syk-related tyrosine kinase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ZAP70</name>
<name type="synonym">SRK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Cell" volume="71" first="649" last="662">
<title>ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain.</title>
<authorList>
<person name="Chan A.C."/>
<person name="Iwashima M."/>
<person name="Turck C.W."/>
<person name="Weiss A."/>
</authorList>
<dbReference type="PubMed" id="1423621"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90598-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD247</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="315" first="935" last="941">
<title>Identification of a novel isoform of ZAP-70, truncated ZAP kinase.</title>
<authorList>
<person name="Kuroyama H."/>
<person name="Ikeda T."/>
<person name="Kasai M."/>
<person name="Yamasaki S."/>
<person name="Tatsumi M."/>
<person name="Utsuyama M."/>
<person name="Saito T."/>
<person name="Hirokawa K."/>
</authorList>
<dbReference type="PubMed" id="14985102"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.01.127"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Leukocyte</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>Blood</tissue>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="Cell" volume="76" first="947" last="958">
<title>Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase.</title>
<authorList>
<person name="Arpaia E."/>
<person name="Shahar M."/>
<person name="Dadi H."/>
<person name="Cohen A."/>
<person name="Roifman C.M."/>
</authorList>
<dbReference type="PubMed" id="8124727"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90368-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 521-547</scope>
<scope>VARIANT IMD48 LEU-GLU-GLN-541 INS</scope>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN IMD48</scope>
<source>
<tissue>Lymphoid tissue</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="J. Exp. Med." volume="181" first="375" last="380">
<title>ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.</title>
<authorList>
<person name="Isakov N."/>
<person name="Wange R.L."/>
<person name="Burgess W.H."/>
<person name="Watts J.D."/>
<person name="Aebersold R."/>
<person name="Samelson L.E."/>
</authorList>
<dbReference type="PubMed" id="7528772"/>
<dbReference type="DOI" id="10.1084/jem.181.1.375"/>
</citation>
<scope>CHARACTERIZATION OF TAM-BINDING</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="2499" last="2508">
<title>Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function.</title>
<authorList>
<person name="Chan A.C."/>
<person name="Dalton M."/>
<person name="Johnson R."/>
<person name="Kong G.H."/>
<person name="Wang T."/>
<person name="Thoma R."/>
<person name="Kurosaki T."/>
</authorList>
<dbReference type="PubMed" id="7781602"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-492 AND TYR-493</scope>
<scope>MUTAGENESIS OF TYR-492 AND TYR-493</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="19641" last="19644">
<title>Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function.</title>
<authorList>
<person name="Bubeck Wardenburg J."/>
<person name="Fu C."/>
<person name="Jackman J.K."/>
<person name="Flotow H."/>
<person name="Wilkinson S.E."/>
<person name="Williams D.H."/>
<person name="Johnson R."/>
<person name="Kong G."/>
<person name="Chan A.C."/>
<person name="Findell P.R."/>
</authorList>
<dbReference type="PubMed" id="8702662"/>
<dbReference type="DOI" id="10.1074/jbc.271.33.19641"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF LCP2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="6765" last="6774">
<title>Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70.</title>
<authorList>
<person name="Zhao Q."/>
<person name="Weiss A."/>
</authorList>
<dbReference type="PubMed" id="8943331"/>
<dbReference type="DOI" id="10.1128/MCB.16.12.6765"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-292</scope>
<scope>MUTAGENESIS OF TYR-292</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="J. Exp. Med." volume="185" first="1877" last="1882">
<title>The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction.</title>
<authorList>
<person name="Wu J."/>
<person name="Zhao Q."/>
<person name="Kurosaki T."/>
<person name="Weiss A."/>
</authorList>
<dbReference type="PubMed" id="9151714"/>
<dbReference type="DOI" id="10.1084/jem.185.10.1877"/>
</citation>
<scope>INTERACTION WITH VAV1</scope>
<scope>MUTAGENESIS OF TYR-315</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="J. Immunol." volume="159" first="3739" last="3747">
<title>In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes.</title>
<authorList>
<person name="Gary-Gouy H."/>
<person name="Lang V."/>
<person name="Sarun S."/>
<person name="Boumsell L."/>
<person name="Bismuth G."/>
</authorList>
<dbReference type="PubMed" id="9378960"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Cell" volume="92" first="83" last="92">
<title>LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation.</title>
<authorList>
<person name="Zhang W."/>
<person name="Sloan-Lancaster J."/>
<person name="Kitchen J."/>
<person name="Trible R.P."/>
<person name="Samelson L.E."/>
</authorList>
<dbReference type="PubMed" id="9489702"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80901-0"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF LAT</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Cell Biol." volume="143" first="613" last="624">
<title>ZAP-70 association with T cell receptor zeta (TCRzeta): fluorescence imaging of dynamic changes upon cellular stimulation.</title>
<authorList>
<person name="Sloan-Lancaster J."/>
<person name="Presley J."/>
<person name="Ellenberg J."/>
<person name="Yamazaki T."/>
<person name="Lippincott-Schwartz J."/>
<person name="Samelson L.E."/>
</authorList>
<dbReference type="PubMed" id="9813084"/>
<dbReference type="DOI" id="10.1083/jcb.143.3.613"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="6285" last="6294">
<title>Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling.</title>
<authorList>
<person name="Di Bartolo V."/>
<person name="Mege D."/>
<person name="Germain V."/>
<person name="Pelosi M."/>
<person name="Dufour E."/>
<person name="Michel F."/>
<person name="Magistrelli G."/>
<person name="Isacchi A."/>
<person name="Acuto O."/>
</authorList>
<dbReference type="PubMed" id="10037717"/>
<dbReference type="DOI" id="10.1074/jbc.274.10.6285"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-315 AND TYR-319</scope>
<scope>MUTAGENESIS OF TYR-315 AND TYR-319</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="9775" last="9780">
<title>SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling.</title>
<authorList>
<person name="Tang J."/>
<person name="Sawasdikosol S."/>
<person name="Chang J.-H."/>
<person name="Burakoff S.J."/>
</authorList>
<dbReference type="PubMed" id="10449770"/>
<dbReference type="DOI" id="10.1073/pnas.96.17.9775"/>
</citation>
<scope>INTERACTION WITH CBL AND SLA</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="26004" last="26011">
<title>Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70.</title>
<authorList>
<person name="Wang H.Y."/>
<person name="Altman Y."/>
<person name="Fang D."/>
<person name="Elly C."/>
<person name="Dai Y."/>
<person name="Shao Y."/>
<person name="Liu Y.C."/>
</authorList>
<dbReference type="PubMed" id="11353765"/>
<dbReference type="DOI" id="10.1074/jbc.M010738200"/>
</citation>
<scope>FUNCTION IN CD3Z UBIQUITINATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="293" first="1037" last="1046">
<title>SPAP2, an Ig family receptor containing both ITIMs and ITAMs.</title>
<authorList>
<person name="Xu M.-J."/>
<person name="Zhao R."/>
<person name="Cao H."/>
<person name="Zhao Z.J."/>
</authorList>
<dbReference type="PubMed" id="12051764"/>
<dbReference type="DOI" id="10.1016/S0006-291X(02)00332-7"/>
</citation>
<scope>INTERACTION WITH FCRL3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Eur. J. Immunol." volume="32" first="568" last="575">
<title>Tyrosine 315 determines optimal recruitment of ZAP-70 to the T cell antigen receptor.</title>
<authorList>
<person name="Di Bartolo V."/>
<person name="Malissen M."/>
<person name="Dufour E."/>
<person name="Sechet E."/>
<person name="Malissen B."/>
<person name="Acuto O."/>
</authorList>
<dbReference type="PubMed" id="11828374"/>
<dbReference type="DOI" id="10.1002/1521-4141(200202)32:2&lt;568::AID-IMMU568>3.0.CO;2-Q"/>
</citation>
<scope>MUTAGENESIS OF TYR-315</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Eur. J. Biochem." volume="269" first="3279" last="3288">
<title>Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells.</title>
<authorList>
<person name="Lindholm C.K."/>
<person name="Henriksson M.L."/>
<person name="Hallberg B."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="12084069"/>
<dbReference type="DOI" id="10.1046/j.1432-1033.2002.03008.x"/>
</citation>
<scope>INTERACTION WITH SHB</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="443" last="448">
<title>Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.</title>
<authorList>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Brill L.M."/>
<person name="Brinker A."/>
<person name="Phung Q.T."/>
<person name="Ericson C."/>
<person name="Sauer K."/>
<person name="Brock A."/>
<person name="Horn D.M."/>
<person name="Schultz P.G."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="12522270"/>
<dbReference type="DOI" id="10.1073/pnas.2436191100"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="8126" last="8131">
<title>NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling.</title>
<authorList>
<person name="Ohtsuka M."/>
<person name="Arase H."/>
<person name="Takeuchi A."/>
<person name="Yamasaki S."/>
<person name="Shiina R."/>
<person name="Suenaga T."/>
<person name="Sakurai D."/>
<person name="Yokosuka T."/>
<person name="Arase N."/>
<person name="Iwashima M."/>
<person name="Kitamura T."/>
<person name="Moriya H."/>
<person name="Saito T."/>
</authorList>
<dbReference type="PubMed" id="15143214"/>
<dbReference type="DOI" id="10.1073/pnas.0401119101"/>
</citation>
<scope>INTERACTION WITH NFAM1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Immunol." volume="175" first="8123" last="8132">
<title>T cell activation-induced CrkII binding to the Zap70 protein tyrosine kinase is mediated by Lck-dependent phosphorylation of Zap70 tyrosine 315.</title>
<authorList>
<person name="Gelkop S."/>
<person name="Gish G.D."/>
<person name="Babichev Y."/>
<person name="Pawson T."/>
<person name="Isakov N."/>
</authorList>
<dbReference type="PubMed" id="16339550"/>
<dbReference type="DOI" id="10.4049/jimmunol.175.12.8123"/>
</citation>
<scope>PHOSPHORYLATION BY LCK</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-248</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Clin. Cancer Res." volume="12" first="726" last="734">
<title>ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia.</title>
<authorList>
<person name="Crespo M."/>
<person name="Villamor N."/>
<person name="Gine E."/>
<person name="Muntanola A."/>
<person name="Colomer D."/>
<person name="Marafioti T."/>
<person name="Jones M."/>
<person name="Camos M."/>
<person name="Campo E."/>
<person name="Montserrat E."/>
<person name="Bosch F."/>
</authorList>
<dbReference type="PubMed" id="16467082"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-05-1531"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="11002" last="11010">
<title>Identification of substrates of human protein-tyrosine phosphatase PTPN22.</title>
<authorList>
<person name="Wu J."/>
<person name="Katrekar A."/>
<person name="Honigberg L.A."/>
<person name="Smith A.M."/>
<person name="Conn M.T."/>
<person name="Tang J."/>
<person name="Jeffery D."/>
<person name="Mortara K."/>
<person name="Sampang J."/>
<person name="Williams S.R."/>
<person name="Buggy J."/>
<person name="Clark J.M."/>
</authorList>
<dbReference type="PubMed" id="16461343"/>
<dbReference type="DOI" id="10.1074/jbc.M600498200"/>
</citation>
<scope>DEPHOSPHORYLATION BY PTN22</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Immunol. Rev." volume="228" first="41" last="57">
<title>The structure, regulation, and function of ZAP-70.</title>
<authorList>
<person name="Au-Yeung B.B."/>
<person name="Deindl S."/>
<person name="Hsu L.Y."/>
<person name="Palacios E.H."/>
<person name="Levin S.E."/>
<person name="Kuriyan J."/>
<person name="Weiss A."/>
</authorList>
<dbReference type="PubMed" id="19290920"/>
<dbReference type="DOI" id="10.1111/j.1600-065X.2008.00753.x"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-603</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Semin. Immunopathol." volume="32" first="107" last="116">
<title>ZAP70: a master regulator of adaptive immunity.</title>
<authorList>
<person name="Fischer A."/>
<person name="Picard C."/>
<person name="Chemin K."/>
<person name="Dogniaux S."/>
<person name="le Deist F."/>
<person name="Hivroz C."/>
</authorList>
<dbReference type="PubMed" id="20135127"/>
<dbReference type="DOI" id="10.1007/s00281-010-0196-x"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2016" name="J. Exp. Med." volume="213" first="399" last="414">
<title>Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination.</title>
<authorList>
<person name="Hu H."/>
<person name="Wang H."/>
<person name="Xiao Y."/>
<person name="Jin J."/>
<person name="Chang J.H."/>
<person name="Zou Q."/>
<person name="Xie X."/>
<person name="Cheng X."/>
<person name="Sun S.C."/>
</authorList>
<dbReference type="PubMed" id="26903241"/>
<dbReference type="DOI" id="10.1084/jem.20151426"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH OTUD7B AND UBASH3B</scope>
<scope>UBIQUITINATION AT LYS-544</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF LYS-304; LYS-538 AND LYS-544</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1995" name="Nature" volume="377" first="32" last="38">
<title>Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor.</title>
<authorList>
<person name="Hatada M.H."/>
<person name="Lu X."/>
<person name="Laird E.R."/>
<person name="Green J."/>
<person name="Morgenstern J.P."/>
<person name="Lou M."/>
<person name="Marr C.S."/>
<person name="Phillips T.B."/>
<person name="Ram M.K."/>
<person name="Theriault K."/>
<person name="Zoller M.J."/>
<person name="Karas L.K."/>
</authorList>
<dbReference type="PubMed" id="7659156"/>
<dbReference type="DOI" id="10.1038/377032a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 3-256 IN COMPLEX WITH CD247</scope>
<scope>INTERACTION WITH CD247</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1999" name="Nature" volume="398" first="84" last="90">
<title>Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.</title>
<authorList>
<person name="Meng W."/>
<person name="Sawasdikosol S."/>
<person name="Burakoff S.J."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="10078535"/>
<dbReference type="DOI" id="10.1038/18050"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 286-297 IN COMPLEX WITH CBL</scope>
<scope>INTERACTION WITH CBL</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2000" name="Cell" volume="102" first="533" last="539">
<title>Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.</title>
<authorList>
<person name="Zheng N."/>
<person name="Wang P."/>
<person name="Jeffrey P.D."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="10966114"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)00057-X"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 289-297 IN COMPLEX WITH CBL AND UBE2L3</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="14176" last="14184">
<title>Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.</title>
<authorList>
<person name="Folmer R.H."/>
<person name="Geschwindner S."/>
<person name="Xue Y."/>
</authorList>
<dbReference type="PubMed" id="12450381"/>
<dbReference type="DOI" id="10.1021/bi026465e"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-256</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="42818" last="42825">
<title>The three-dimensional structure of the ZAP-70 kinase domain in complex with staurosporine: implications for the design of selective inhibitors.</title>
<authorList>
<person name="Jin L."/>
<person name="Pluskey S."/>
<person name="Petrella E.C."/>
<person name="Cantin S.M."/>
<person name="Gorga J.C."/>
<person name="Rynkiewicz M.J."/>
<person name="Pandey P."/>
<person name="Strickler J.E."/>
<person name="Babine R.E."/>
<person name="Weaver D.T."/>
<person name="Seidl K.J."/>
</authorList>
<dbReference type="PubMed" id="15292186"/>
<dbReference type="DOI" id="10.1074/jbc.M407096200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 327-606 IN COMPLEX WITH STAUROSPORINE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF ASP-479</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Cell" volume="129" first="735" last="746">
<title>Structural basis for the inhibition of tyrosine kinase activity of ZAP-70.</title>
<authorList>
<person name="Deindl S."/>
<person name="Kadlecek T.A."/>
<person name="Brdicka T."/>
<person name="Cao X."/>
<person name="Weiss A."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="17512407"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.03.039"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-606 OF MUTANT ASN-461 IN COMPLEX WITH MAGNESIUM AND ATP ANALOG</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF TRP-131; LEU-133; ALA-141; SER-144; GLN-145; PRO-147; TYR-315; TYR-319; ASP-461; TYR-597 AND TYR-598</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1994" name="Science" volume="264" first="1599" last="1601">
<title>ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency.</title>
<authorList>
<person name="Chan A.C."/>
<person name="Kadlecek T.A."/>
<person name="Elder M.E."/>
<person name="Filipovich A.H."/>
<person name="Kuo W.-L."/>
<person name="Iwashima M."/>
<person name="Parslow T.G."/>
<person name="Weiss A."/>
</authorList>
<dbReference type="PubMed" id="8202713"/>
<dbReference type="DOI" id="10.1126/science.8202713"/>
</citation>
<scope>VARIANT IMD48 ARG-518</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2001" name="Immunology" volume="103" first="164" last="171">
<title>Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.</title>
<authorList>
<person name="Toyabe S."/>
<person name="Watanabe A."/>
<person name="Harada W."/>
<person name="Karasawa T."/>
<person name="Uchiyama M."/>
</authorList>
<dbReference type="PubMed" id="11412303"/>
<dbReference type="DOI" id="10.1046/j.1365-2567.2001.01246.x"/>
</citation>
<scope>VARIANT IMD48 HIS-465</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2001" name="J. Immunol." volume="166" first="656" last="661">
<title>Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70.</title>
<authorList>
<person name="Elder M.E."/>
<person name="Skoda-Smith S."/>
<person name="Kadlecek T.A."/>
<person name="Wang F."/>
<person name="Wu J."/>
<person name="Weiss A."/>
</authorList>
<dbReference type="PubMed" id="11123350"/>
<dbReference type="DOI" id="10.4049/jimmunol.166.1.656"/>
</citation>
<scope>VARIANT IMD48 CYS-465</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-175; LEU-191; GLU-448 AND LEU-523</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Eur. J. Pediatr." volume="168" first="87" last="93">
<title>Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency.</title>
<authorList>
<person name="Turul T."/>
<person name="Tezcan I."/>
<person name="Artac H."/>
<person name="de Bruin-Versteeg S."/>
<person name="Barendregt B.H."/>
<person name="Reisli I."/>
<person name="Sanal O."/>
<person name="van Dongen J.J."/>
<person name="van der Burg M."/>
</authorList>
<dbReference type="PubMed" id="18509675"/>
<dbReference type="DOI" id="10.1007/s00431-008-0718-x"/>
</citation>
<scope>VARIANTS IMD48 ARG-337; VAL-507 AND ARG-564</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2016" name="J. Exp. Med." volume="213" first="155" last="165">
<title>A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70.</title>
<authorList>
<person name="Chan A.Y."/>
<person name="Punwani D."/>
<person name="Kadlecek T.A."/>
<person name="Cowan M.J."/>
<person name="Olson J.L."/>
<person name="Mathes E.F."/>
<person name="Sunderam U."/>
<person name="Fu S.M."/>
<person name="Srinivasan R."/>
<person name="Kuriyan J."/>
<person name="Brenner S.E."/>
<person name="Weiss A."/>
<person name="Puck J.M."/>
</authorList>
<dbReference type="PubMed" id="26783323"/>
<dbReference type="DOI" id="10.1084/jem.20150888"/>
</citation>
<scope>VARIANTS ADMIO2 TRP-192 AND PRO-360</scope>
<scope>CHARACTERIZATION OF VARIANTS ADMIO2 TRP-192 AND PRO-360</scope>
<scope>INVOLVEMENT IN ADMIO2</scope>
<scope>INTERACTION WITH CD247</scope>
<scope>MUTAGENESIS OF ARG-37; ARG-190; 315-TYR--TYR-319; ASP-327 AND LYS-362</scope>
</reference>
<comment type="function">
<text evidence="21 24 26 34 36 39 41 45">Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane. This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR).</text>
</comment>
<comment type="catalytic activity">
<text evidence="15 28">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="28">Activated by phosphorylation at Tyr-493 in the activation loop. Inhibited by staurosporine.</text>
</comment>
<comment type="subunit">
<text evidence="12 17 18 19 24 25 26 27 35 36 37 43">Interacts with CD247/CD3Z; this interaction docks ZAP70 at the stimulated TCR (PubMed:1423621, PubMed:7659156, PubMed:26783323). Interacts with NFAM1 (PubMed:15143214). Interacts with adapter protein SLA; this interaction negatively regulates T-cell receptor signaling (PubMed:10449770). Interacts with FCRL3 (PubMed:12051764). Interacts with VAV1 (PubMed:9151714). Interacts with CBL; this interaction promotes ubiquitination, internalization and subsequent degradation of CD247/CD3Z (PubMed:10449770, PubMed:10078535). Identified in a complex with CBL and UBE2L3 (PubMed:10966114). Interacts with SHB (PubMed:12084069). Interacts with adapter protein SLA2; this interaction negatively regulates T-cell receptor signaling. Interacts with CBLB. Interacts (via SH2 domains) with RHOH; this interaction regulates ZAP70 subcellular localization. Interacts with DEF6 (By similarity). Interacts (ubiquitinated form) with OTUD7B and UBASH3B (PubMed:26903241).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-1165705">
<id>P20963</id>
<label>CD247</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-1211297">
<id>P07766</id>
<label>CD3E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
<label>PTPN22</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211276"/>
<interactant intactId="EBI-8846415">
<id>Q8BGG7</id>
<label>Ubash3b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="46">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="46">Cell membrane</location>
<topology evidence="46">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="11">In quiescent T-lymphocytes, it is cytoplasmic. Upon TCR activation, it is recruited at the plasma membrane by interacting with CD247/CD3Z. Colocalizes together with RHOH in the immunological synapse. RHOH is required for its proper localization to the cell membrane and cytoskeleton fractions in the thymocytes (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P43403-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P43403-2</id>
<name>2</name>
<name>TZK</name>
<sequence type="described" ref="VSP_031156"/>
</isoform>
<isoform>
<id>P43403-3</id>
<name>3</name>
<sequence type="described" ref="VSP_031157 VSP_031158"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="26 30 44">Expressed in T- and natural killer cells. Also present in early thymocytes and pro/pre B-cells.</text>
</comment>
<comment type="domain">
<text evidence="11 34">Composed of 2 N-terminal SH2 domains and a C-terminal kinase domain. The tandem SH2 domains bind to the doubly phosphorylated tyrosine-based activation motif (ITAM) of CD247/CD3Z and the non-canonical phosphorylated tyrosine-based activation motif (TAM) of RHOH (By similarity). The interdomain B located between the second SH2 and the kinase domain contains 3 tyrosines (Tyr-292, Tyr-315, Tyr-319) that are phosphorylated following TCR activation. These sites have been implicated in binding to other signaling molecules including CBL or VAV1. Thus, ZAP70 can also function as a scaffold by recruiting additional factors to the stimulated TCR complex.</text>
</comment>
<comment type="PTM">
<text evidence="16 26 29 42">Phosphorylated on tyrosine residues upon T-cell antigen receptor (TCR) stimulation. Phosphorylation of Tyr-315 and Tyr-319 are essential for ZAP70 positive function on T-lymphocyte activation whereas Tyr-292 has a negative regulatory role. Within the C-terminal kinase domain, Tyr-492 and Tyr-493 are phosphorylated after TCR induction, Tyr-492 playing a negative regulatory role and Tyr-493 a positive. Tyr-493 is dephosphorylated by PTN22.</text>
</comment>
<comment type="PTM">
<text evidence="36">Ubiquitinated in response to T cell activation. Deubiquitinated by OTUD7B.</text>
</comment>
<comment type="disease" evidence="20 22 33 39 40">
<disease id="DI-02295">
<name>Immunodeficiency 48</name>
<acronym>IMD48</acronym>
<description>A form of severe immunodeficiency characterized by a selective absence of CD8+ T-cells.</description>
<dbReference type="MIM" id="269840"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="35">
<disease id="DI-04749">
<name>Autoimmune disease, multisystem, infantile-onset, 2</name>
<acronym>ADMIO2</acronym>
<description>An autosomal recessive, autoimmune disorder characterized by systemic manifestations including blistering skin disease, uncontrollable bullous pemphigoid, inflammatory colitis, autoimmune hypothyroidism, proteinuria and nephrotic syndrome.</description>
<dbReference type="MIM" id="617006"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="13">Belongs to the protein kinase superfamily. Tyr protein kinase family. SYK/ZAP-70 subfamily.</text>
</comment>
<comment type="online information" name="ZAP70base">
<link uri="http://structure.bmc.lu.se/idbase/ZAP70base/"/>
<text>ZAP70 mutation db</text>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="L05148">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB083211">
<property type="protein sequence ID" value="BAC43747.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC016699">
<property type="protein sequence ID" value="AAX93187.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039039">
<property type="protein sequence ID" value="AAH39039.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053878">
<property type="protein sequence ID" value="AAH53878.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33254.1">
<molecule id="P43403-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33255.1">
<molecule id="P43403-2"/>
</dbReference>
<dbReference type="PIR" id="A44266">
<property type="entry name" value="A44266"/>
</dbReference>
<dbReference type="PIR" id="A49955">
<property type="entry name" value="A49955"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001070.2">
<molecule id="P43403-1"/>
<property type="nucleotide sequence ID" value="NM_001079.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_997402.1">
<molecule id="P43403-2"/>
<property type="nucleotide sequence ID" value="NM_207519.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.234569"/>
<dbReference type="PDB" id="1FBV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B=289-297"/>
</dbReference>
<dbReference type="PDB" id="1M61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-256"/>
</dbReference>
<dbReference type="PDB" id="1U59">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=327-606"/>
</dbReference>
<dbReference type="PDB" id="2CBL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B=286-297"/>
</dbReference>
<dbReference type="PDB" id="2OQ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=3-256"/>
</dbReference>
<dbReference type="PDB" id="2OZO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-606"/>
</dbReference>
<dbReference type="PDB" id="2Y1N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B/D=286-297"/>
</dbReference>
<dbReference type="PDB" id="3ZNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="B/F/J/N=286-297"/>
</dbReference>
<dbReference type="PDB" id="4A4B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="B=286-297"/>
</dbReference>
<dbReference type="PDB" id="4A4C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="B=286-297"/>
</dbReference>
<dbReference type="PDB" id="4K2R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-606"/>
</dbReference>
<dbReference type="PDB" id="4XZ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-259"/>
</dbReference>
<dbReference type="PDB" id="4XZ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1-259"/>
</dbReference>
<dbReference type="PDBsum" id="1FBV"/>
<dbReference type="PDBsum" id="1M61"/>
<dbReference type="PDBsum" id="1U59"/>
<dbReference type="PDBsum" id="2CBL"/>
<dbReference type="PDBsum" id="2OQ1"/>
<dbReference type="PDBsum" id="2OZO"/>
<dbReference type="PDBsum" id="2Y1N"/>
<dbReference type="PDBsum" id="3ZNI"/>
<dbReference type="PDBsum" id="4A4B"/>
<dbReference type="PDBsum" id="4A4C"/>
<dbReference type="PDBsum" id="4K2R"/>
<dbReference type="PDBsum" id="4XZ0"/>
<dbReference type="PDBsum" id="4XZ1"/>
<dbReference type="ProteinModelPortal" id="P43403"/>
<dbReference type="SMR" id="P43403"/>
<dbReference type="BioGrid" id="113367">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="DIP" id="DIP-38781N"/>
<dbReference type="IntAct" id="P43403">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="MINT" id="MINT-110540"/>
<dbReference type="STRING" id="9606.ENSP00000264972"/>
<dbReference type="BindingDB" id="P43403"/>
<dbReference type="ChEMBL" id="CHEMBL2803"/>
<dbReference type="DrugBank" id="DB02010">
<property type="generic name" value="Staurosporine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2285"/>
<dbReference type="iPTMnet" id="P43403"/>
<dbReference type="PhosphoSitePlus" id="P43403"/>
<dbReference type="BioMuta" id="ZAP70"/>
<dbReference type="DMDM" id="1177044"/>
<dbReference type="MaxQB" id="P43403"/>
<dbReference type="PaxDb" id="P43403"/>
<dbReference type="PeptideAtlas" id="P43403"/>
<dbReference type="PRIDE" id="P43403"/>
<dbReference type="DNASU" id="7535"/>
<dbReference type="Ensembl" id="ENST00000264972">
<molecule id="P43403-1"/>
<property type="protein sequence ID" value="ENSP00000264972"/>
<property type="gene ID" value="ENSG00000115085"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000451498">
<molecule id="P43403-2"/>
<property type="protein sequence ID" value="ENSP00000400475"/>
<property type="gene ID" value="ENSG00000115085"/>
</dbReference>
<dbReference type="GeneID" id="7535"/>
<dbReference type="KEGG" id="hsa:7535"/>
<dbReference type="UCSC" id="uc002syd.2">
<molecule id="P43403-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7535"/>
<dbReference type="DisGeNET" id="7535"/>
<dbReference type="GeneCards" id="ZAP70"/>
<dbReference type="GeneReviews" id="ZAP70"/>
<dbReference type="HGNC" id="HGNC:12858">
<property type="gene designation" value="ZAP70"/>
</dbReference>
<dbReference type="HPA" id="CAB002625"/>
<dbReference type="HPA" id="HPA003134"/>
<dbReference type="MalaCards" id="ZAP70"/>
<dbReference type="MIM" id="176947">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="269840">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617006">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P43403"/>
<dbReference type="OpenTargets" id="ENSG00000115085"/>
<dbReference type="Orphanet" id="911">
<property type="disease" value="Combined immunodeficiency due to ZAP70 deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37447"/>
<dbReference type="eggNOG" id="ENOG410IH0T">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000113264"/>
<dbReference type="HOVERGEN" id="HBG001540"/>
<dbReference type="InParanoid" id="P43403"/>
<dbReference type="KO" id="K07360"/>
<dbReference type="OMA" id="YKARTAG"/>
<dbReference type="OrthoDB" id="EOG091G07KU"/>
<dbReference type="PhylomeDB" id="P43403"/>
<dbReference type="TreeFam" id="TF351629"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202430">
<property type="pathway name" value="Translocation of ZAP-70 to Immunological synapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202433">
<property type="pathway name" value="Generation of second messenger molecules"/>
</dbReference>
<dbReference type="SignaLink" id="P43403"/>
<dbReference type="SIGNOR" id="P43403"/>
<dbReference type="EvolutionaryTrace" id="P43403"/>
<dbReference type="GeneWiki" id="ZAP70"/>
<dbReference type="GenomeRNAi" id="7535"/>
<dbReference type="PMAP-CutDB" id="P43403"/>
<dbReference type="PRO" id="PR:P43403"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115085"/>
<dbReference type="CleanEx" id="HS_ZAP70"/>
<dbReference type="Genevisible" id="P43403">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001772">
<property type="term" value="C:immunological synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042101">
<property type="term" value="C:T cell receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042113">
<property type="term" value="P:B cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043366">
<property type="term" value="P:beta selection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045060">
<property type="term" value="P:negative thymic T cell selection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046638">
<property type="term" value="P:positive regulation of alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046641">
<property type="term" value="P:positive regulation of alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050850">
<property type="term" value="P:positive regulation of calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045582">
<property type="term" value="P:positive regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045059">
<property type="term" value="P:positive thymic T cell selection"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042110">
<property type="term" value="P:T cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070489">
<property type="term" value="P:T cell aggregation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072678">
<property type="term" value="P:T cell migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.930.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR023420">
<property type="entry name" value="Kinase_SYK/ZAP-70_inter-SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR012234">
<property type="entry name" value="Tyr_kinase_non-rcpt_SYK/ZAP70"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000604">
<property type="entry name" value="TyrPK_SYK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0705">SCID</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Tyrosine-protein kinase ZAP-70" id="PRO_0000088168">
<location>
<begin position="1"/>
<end position="619"/>
</location>
</feature>
<feature type="domain" description="SH2 1" evidence="14">
<location>
<begin position="10"/>
<end position="102"/>
</location>
</feature>
<feature type="domain" description="SH2 2" evidence="14">
<location>
<begin position="163"/>
<end position="254"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="13">
<location>
<begin position="338"/>
<end position="600"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="345"/>
<end position="352"/>
</location>
</feature>
<feature type="region of interest" description="Interdomain A">
<location>
<begin position="103"/>
<end position="162"/>
</location>
</feature>
<feature type="region of interest" description="Interdomain B">
<location>
<begin position="255"/>
<end position="337"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="13 15 28 32">
<location>
<position position="461"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="369"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="289"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10 42">
<location>
<position position="292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by LCK" evidence="16">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="16">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="38">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="38">
<location>
<position position="493"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="603"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="36">
<location>
<position position="544"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_031156" evidence="47">
<location>
<begin position="1"/>
<end position="307"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_031157" evidence="48">
<location>
<begin position="1"/>
<end position="126"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_031158" evidence="48">
<original>VRQTWKLE</original>
<variation>MRLGPRWK</variation>
<location>
<begin position="127"/>
<end position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55964305." id="VAR_041846" evidence="31">
<original>R</original>
<variation>L</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56403250." id="VAR_041847" evidence="31">
<original>P</original>
<variation>L</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO2; decreases interaction with phosphorylated CD247; decreases ZAP70 phosphorylation; no effect on subcellular localization of CD69 at the cell surface; dbSNP:rs199840952." id="VAR_077137" evidence="35">
<original>R</original>
<variation>W</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48." id="VAR_065623" evidence="33">
<original>L</original>
<variation>R</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO2; no effect on interaction with phosphorylated CD247; increases TCR-induced Y-319 and Y-493 phosphorylation of ZAP70 and phosphorylation of LAT and LCP2; increases subcellular localization of CD69 at the cell surface; weakly decreases autoinhibition conformation; dbSNP:rs869025224." id="VAR_077138" evidence="35">
<original>R</original>
<variation>P</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In a head and neck squamous cell carcinoma sample; somatic mutation." id="VAR_041848" evidence="31">
<original>G</original>
<variation>E</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48; dbSNP:rs113994174." id="VAR_065624" evidence="20">
<original>R</original>
<variation>C</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48; dbSNP:rs137853201." id="VAR_015538" evidence="22">
<original>R</original>
<variation>H</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48." id="VAR_065625" evidence="33">
<original>A</original>
<variation>V</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48; dbSNP:rs104893674." id="VAR_006351" evidence="40">
<original>S</original>
<variation>R</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56189815." id="VAR_041849" evidence="31">
<original>W</original>
<variation>L</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48." id="VAR_038688" evidence="39">
<original>K</original>
<variation>KLEQ</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD48." id="VAR_065626" evidence="33">
<original>C</original>
<variation>R</variation>
<location>
<position position="564"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with phosphorylated CD247; when associated with K-190." evidence="35">
<original>R</original>
<variation>K</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity." evidence="32">
<original>W</original>
<variation>A</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity." evidence="32">
<original>L</original>
<variation>A</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity." evidence="32">
<original>A</original>
<variation>E</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity after activation by LCK." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity after activation by LCK." evidence="32">
<original>Q</original>
<variation>A</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity after activation by LCK." evidence="32">
<original>P</original>
<variation>A</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with phosphorylated CD247; when associated with K-37." evidence="35">
<original>R</original>
<variation>K</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces constitutive TCR stimulation-independent NFAT induction." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ubiquitination." evidence="36">
<original>K</original>
<variation>R</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity.">
<original>V</original>
<variation>A</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases strongly constitutive kinase activity on LAT phosphorylation." evidence="35">
<original>YESPY</original>
<variation>AESPA</variation>
<location>
<begin position="315"/>
<end position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity; when associated with F-319." evidence="16 23 32 43">
<original>Y</original>
<variation>A</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity; when associated with F-319. About 75% loss of CD247/CD3Z-binding in stimulated TCR and complete loss of VAV1 interaction." evidence="16 23 32 43">
<original>Y</original>
<variation>F</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity; when associated with F-315." evidence="16 32">
<original>Y</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased constitutive kinase activity; when associated with F-315. About 80% loss of TCR-induced NFAT activation." evidence="16 32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation." evidence="35">
<original>D</original>
<variation>P</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation." evidence="35">
<original>K</original>
<variation>E</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="32">
<original>D</original>
<variation>N</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="28">
<original>D</original>
<variation>N</variation>
<location>
<position position="479"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases kinase activity." evidence="38">
<original>Y</original>
<variation>F</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs kinase activity." evidence="38">
<original>Y</original>
<variation>F</variation>
<location>
<position position="493"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ubiquitination." evidence="36">
<original>K</original>
<variation>R</variation>
<location>
<position position="538"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased ubiquitination." evidence="36">
<original>K</original>
<variation>R</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity after activation by LCK." evidence="32">
<original>Y</original>
<variation>A</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity after activation by LCK." evidence="32">
<original>Y</original>
<variation>A</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="4"/>
<end position="7"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="11"/>
<end position="14"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="17"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="46"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="55"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="69"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="77"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="80"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="94"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="114"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="135"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="157"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="170"/>
<end position="178"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="186"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="197"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="207"/>
<end position="215"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="229"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="232"/>
<end position="241"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="246"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="309"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="316"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="322"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="337"/>
<end position="345"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="350"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="364"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="377"/>
<end position="392"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="401"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="422"/>
<end position="426"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="435"/>
<end position="454"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="464"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="467"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="474"/>
<end position="477"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="482"/>
<end position="485"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="508"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="518"/>
<end position="533"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="534"/>
<end position="536"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="539"/>
<end position="542"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="546"/>
<end position="553"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="566"/>
<end position="574"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="580"/>
<end position="582"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="586"/>
<end position="601"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1M61"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1U59"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OQ1"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OZO"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K2R"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XZ1"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15144186"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250"/>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P43404"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10037717"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10078535"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10449770"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10966114"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11123350"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11353765"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11412303"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11828374"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12051764"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12084069"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1423621"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15143214"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15292186"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16339550"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16467082"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17512407"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18509675"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20135127"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26783323"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26903241"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7659156"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7781602"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8124727"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8202713"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8702662"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8943331"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9151714"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9378960"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9489702"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9813084"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14985102"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<sequence length="619" mass="69872" checksum="D1E1A8EC66FA116F" modified="1995-11-01" version="1">
MPDPAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFP
IERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRD
AMVRDYVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERKLYSG
AQTDGKFLLRPRKEQGTYALSLIYGKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYLK
LKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARIT
SPDKPRPMPMDTSVYESPYSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR
KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGG
PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF
GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY
KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL
ASKVEGPPGSTQKAEAACA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>